Registrieren

Registierung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

Immunotherapy Combo Improves Bladder Cancer EFS

The phase 3 VOLGA trial looks at perioperative durvalumab plus enfortumab vedotin, with and without tremelimumab, for muscle-invasive bladder cancer.

Ähnliche Seiten

https://www.medscape.com/viewarticle/personalized-melanoma-vaccine-improves-recurrence-free-2026a100148e

Personalized Melanoma Vaccine Improves RFS in Phase 3 Trial

https://www.medscape.com/viewarticle/personalized-melanoma-vaccine-improves-recurrence-free-2026a100148e
https://www.medscape.com/viewarticle/tarlatamab-maintenance-therapy-combo-boosts-lung-cancer-2026a100148u

Tarlatamab Maintenance Combo Boosts Lung Cancer Survival

https://www.medscape.com/viewarticle/tarlatamab-maintenance-therapy-combo-boosts-lung-cancer-2026a100148u
https://www.medscape.com/viewarticle/higher-alignment-lifestyle-guidelines-linked-better-physical-2026a10012qg

Healthy Lifestyle Tied to Better Health After Breast Cancer

https://www.medscape.com/viewarticle/higher-alignment-lifestyle-guidelines-linked-better-physical-2026a10012qg
https://www.medscape.com/viewarticle/do-industry-payments-influence-end-life-cancer-care-2026a10013yr

Do Industry Payments Influence End-of-Life Cancer Care?

https://www.medscape.com/viewarticle/do-industry-payments-influence-end-life-cancer-care-2026a10013yr
https://www.medscape.com/viewarticle/how-scientists-finally-cracked-ras-pancreatic-cancer-2026a10010ok

How Scientists Finally Cracked RAS in Pancreatic Cancer

https://www.medscape.com/viewarticle/how-scientists-finally-cracked-ras-pancreatic-cancer-2026a10010ok
https://www.medscape.com/viewarticle/biopsy-based-cfdna-could-reveal-increased-risk-cancer-2026a1001235

Biopsy Based on cfDNA Could Reveal Increased Risk for Cancer

https://www.medscape.com/viewarticle/biopsy-based-cfdna-could-reveal-increased-risk-cancer-2026a1001235